Literature DB >> 1836742

Pustular eruption at the site of subcutaneous injection of recombinant human granulocyte-macrophage colony-stimulating factor.

J Passweg1, U Buser, A Tichelli, A Gratwohl, B Speck.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1836742     DOI: 10.1007/bf01709655

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  5 in total

Review 1.  Haemopoietic growth factors 1.

Authors:  D Metcalf
Journal:  Lancet       Date:  1989-04-15       Impact factor: 79.321

2.  Neutrophil migration is defective during recombinant human granulocyte-macrophage colony-stimulating factor infusion after autologous bone marrow transplantation in humans.

Authors:  W P Peters; A Stuart; M L Affronti; C S Kim; R E Coleman
Journal:  Blood       Date:  1988-10       Impact factor: 22.113

3.  [Emergency therapy with granulocyte-macrophage colony-stimulating factor (GM-CSF)].

Authors:  A Gratwohl; H Dazzi; A Tichelli; C Stebler; M Wernli; C Thomssen; I Kim; A Dieterle; R Obrist; A Stern
Journal:  Schweiz Med Wochenschr       Date:  1991-03-23

4.  Intravenous administration of recombinant human granulocyte-macrophage colony-stimulating factor causes a cutaneous eruption.

Authors:  T D Horn; P J Burke; J E Karp; A F Hood
Journal:  Arch Dermatol       Date:  1991-01

5.  Effects of bacterially synthesized recombinant human granulocyte-macrophage colony-stimulating factor in patients with advanced malignancy.

Authors:  G J Lieschke; D Maher; J Cebon; M O'Connor; M Green; W Sheridan; A Boyd; M Rallings; E Bonnem; D Metcalf
Journal:  Ann Intern Med       Date:  1989-03-01       Impact factor: 25.391

  5 in total
  1 in total

Review 1.  Clinical toxicity of cytokines used as haemopoietic growth factors.

Authors:  T Vial; J Descotes
Journal:  Drug Saf       Date:  1995-12       Impact factor: 5.606

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.